Lemaitre Vascular (LMAT) Cash & Current Investments (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Cash & Current Investments for 17 consecutive years, with $367.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments rose 21.38% year-over-year to $367.2 million; the TTM figure through Mar 2026 stood at $367.2 million (up 21.38% YoY), while the FY2025 annual figure was $359.1 million, up 19.82% from the prior year.
• Cash & Current Investments grew to $367.2 million in Q1 2026 per LMAT's latest filing, from $359.1 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $367.2 million in Q1 2026 and bottomed at $70.9 million in Q1 2022.
• Historically, Cash & Current Investments has averaged $177.6 million across 5 years, with a median of $108.3 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Current Investments soared 247.87% — and 2023, when it gained 14.28%.
• Lemaitre Vascular's Cash & Current Investments stood at $82.7 million in 2022, then grew by 27.07% to $105.1 million in 2023, then jumped by 185.25% to $299.7 million in 2024, then increased by 19.82% to $359.1 million in 2025, then advanced by 2.26% to $367.2 million in 2026.
• Business Quant data shows LMAT's Cash & Current Investments at $367.2 million in Q1 2026, $359.1 million in Q4 2025, and $343.1 million in Q3 2025.